X-Lab Ltd

Digital solutions for diagnostic healthcare organisations

X-Lab Ltd logo
21-100 employees
  • Healthcare
  • B2B
  • SaaS
  • MedTech
Leeds, UK

Company mission

To find opportunities to improve systems integration for the global diagnostics community, enabling healthcare providers to deliver better quality care.

Top investors

36% female employees

25% employee growth in 12 months

Our take

X-Lab is a high growth health tech start up that delivers products designed to improve patient and clinical outcomes. They work with the UK NHS, the private sector and on an international scale. Having been around since 2006, it's been in the last few years the company has seen the most dramatic changes and growth.

Its core product, Labgnostic, is a service which connects almost 200 diagnostic organisations (primarily pathology labs) together through exchange hubs across Europe and the US. Historically marketed under NPEx (the National Pathology Exchange), it has now become the market leader in the UK.

As X-Lab continues to grow, they are looking to expand through both the diversity of their product offering and with their geographic reach. As part of this, its new product - LabReach - is in development in the UK. This will act as an order communications portal to enable end users, from any organisation or location, to more easily order tests and receive results from labs.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • Life Insurance
  • Company outings, social events and wellbeing initiatives
  • Choice of hardware + home working setup
  • Remote-first working and flexible working hours, with modern comfortable offices in Leeds and London for co-working
  • Comprehensive Employee Assistance Programme to provide mental health, counselling and financial management support
  • 28 days holiday, in addition to UK bank holidays
  • Pension scheme, 5% for 3% contribution
  • EMI Options Scheme
  • Birthday Meal
  • Cycle to Work Scheme
  • A flat organisational structure with loose, but supportive, line management

Funding (1 round)

Feb 2019

$0.2m

GRANT

Total funding: $0.2m

This company has top investors

Leadership